Industry News

Vanda Pharmaceuticals Inc. today announced that Judge Gregory M. Sleet of the United States District Court for the District of Delaware ruled that Roxane Laboratories Inc. infringed U.S. RE39, 198 and 8,586,610 by submitting to the FDA an ANDA seeking permission to market a generic version of Fanapt ® before the expiration of Vanda's patents. "We are very pleased that the court found both patents valid, found that Roxane's ANDA infringes the'..."/>
Vanda Patents Found Valid and Infringed in Fanapt® ANDA Litigation
Cigna's collaborative care associates Advances Cigna's commitment to have 50 percent of payments in alternative payment models and 90 percent in value-based arrangements by 2018. BLOOMFIELD, Conn.---- Cigna continues to expand Cigna Collaborative Care, its value-based..."/>
Cigna Collaborates With Doctors to Improve Care for People Fighting Cancer
Medtronic PLC on Thursday reported lower adjusted net income in the most recent quarter and reiterated sales expectations for the year. The company's adjusted profit amounted to $1.03 in diluted earnings per share, two cents above Wall Street forecasts. Revenue was nearly in line with what had been expected."/>
Medtronic beats forecasts on earnings, despite lower net income [Star Tribune (Minneapolis)]
Mylan NV responded to mounting criticism of price hikes on its EpiPen by expanding programs that could cut the out-of-pocket costs of the allergy drug by as much as half. Mylan, which is based in the Netherlands and run from offices in Cecil, said Thursday that a patient discount card would cut the cost of an EpiPen two-pack by up to $300. The drug injectors, which are used to treat severe allergic reactions, can cost up to $600 a pair. In addition to the discount card, which..."/>
Mylan says it will expand programs that lower EpiPen costs [The Pittsburgh Tribune-Review]
Patterson Companies today announced that the company will be presenting at the Baird 2016 Global Healthcare Conference on September 8, 2016, in New York. The formal presentation will begin at 1:25 p.m. ET. About Patterson Companies, Inc. Patterson Companies, Inc. is a value-added distributor serving the dental and animal health markets."/>
Patterson Companies to Present at the Baird 2016 Global Healthcare Conference
Meridian Bioscience, Inc. was awarded 1 st place for innovation in emergency treatment and point-of-care testing for its illumi gene ® Malaria test at the 2016 JIB/ACNBH Conference. Innovations from worldwide companies contributing to the development of the Medical Biology..."/>
Meridian Malaria Test Wins Prestigious Innovation Award
Juno Therapeutics, Inc. between June 4, 2016 and July 7, 2016, inclusive. If you purchased or acquired Juno securities during the Class Period, you may move the Court for appointment as lead plaintiff by no..."/>
JUNO INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Securities Class Action Against Juno Therapeutics, Inc.
Teladoc’ s victory in federal court. LEWISVILLE, Texas---- Teladoc, Inc., the nation’ s first and largest telehealth provider, today announced the U.S. Patent and Trademark Office has invalidated the major elements of a telemedicine patent held by American Well Corporation on the basis that they were not patentable because American Well did not invent them."/>
Teladoc Secures Second Consecutive Win in Patent Dispute
Atossa Genetics Inc. today announced a reverse split of its common stock at a ratio of 1- for-15, effective August 26, 2016, and that the Company's common stock will begin trading on a split-adjusted basis when the market opens on August 26, 2016. The reverse split was approved by the Company's stockholders at an annual meeting of the stockholders held on May 18, 2016. The Company's common stock will continue to trade on the NASDAQ Capital Market under the..."/>
Atossa Genetics Announces Reverse Stock Split
Diplomat Pharmacy, Inc., the nation's largest independent specialty pharmacy, has announced that Phil Hagerman, Chairman& CEO, and Sean Whelan, CFO, will present at four upcoming investor conferences. Whelan are scheduled to participate in the Robert W. Baird 2016 Healthcare Conference in New York on Wednesday, September 7, 2016 at 10:50 AM ET. Whelan are scheduled to participate in the Wells Fargo 2016 Healthcare Conference in Boston on Thursday, September 8, 2016..."/>
Diplomat to Participate in Upcoming Investor Conferences - Diplomat
Medovex Corp., a developer of medical technology products, announced today that it has added orthopedic industry veteran Ron Lawson to its Board of Directors. Ron Lawson's 35 plus years of experience in the orthopedic industry include the role as Senior Vice President of Worldwide Sales and Customer Service for Pfizer's Orthopedic Division, Howmedica. In 1998, he became part of the Stryker Corporation with Stryker's acquisition of Howmedica."/>
Medovex Corporation Adds 35 Year Orthopedic Industry Veteran Ron Lawson to Board of Directors
Shanghai Pharmaceuticals Released 2016 Interim Results
Medtronic PLC reported lower adjusted net income for the quarter ended July 29, but higher-than-expected earnings per share from sales of medical devices. Adjusted net income dropped to $1.44 billion, down 1 percent from the same period last year at the Minnesota-run maker of advanced medical devices and healthcare supplies. The comparison to last year's net income was complicated because the same quarter a year ago included an extra week of sales."/>
Medtronic beats forecasts on earnings, despite lower net income [Star Tribune (Minneapolis)]
Mylan NV by striking down two patents held by Israel-based Teva Pharmaceutical Industries Ltd for its blockbuster drug Copaxone 40 mg/mL formulation. "The US PTO has ruled in favor of Mylan in its inter partes review proceeding and found all claims of two related Copaxone 40 mg patents to be unpatentable," Natco said in a statement."/>
US patent office rules in favour of Natco Pharma's US partner Mylan [Mint, New Delhi]
Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases, today announced that it has been awarded a contract for up to $13.2 million in total funding from the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority for the development and commercialization of the Company’ s rapid POC Zika test and..."/>
Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus
Nix® Launches First-Ever Lice Tracker
Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy, today announced that it will present at five investor conferences in September. On Wednesday, September..."/>
Merit Medical to Present at Five Conferences
Provectus Biopharmaceuticals, Inc., a clinical-stage oncology and dermatology biopharmaceutical company, today announced the pricing of a "best efforts" public offering of 240,000 shares of Series B Convertible Preferred Stock and warrants initially exercisable to purchase an aggregate of 24,000,000 shares of common stock with a public offering price of $25.00 for a combination of one share of Series B Convertible Preferred Stock and a warrant to..."/>
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $6 Million
OneSavings Bank said it will continue to focus on what it does best. In an interim update the challenger bank said underlying pre-tax profit was pounds sterling 64.6 m in the first six months of the year, up 36 pc on the same period a year ago. Assets on its books have grown 20.8 pc to pounds sterling 6.3 bn."/>
Daily Mail, London, market report column [Daily Mail, London]

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary602 Articles
Information Technology558 Articles
Financials468 Articles
Health Care341 Articles
Industrials331 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at